B

Halozyme Therapeutics, Inc. HALO

NASDAQ
Recommendation
Dividend Power Score
Day's Range
$95.01$97.96
Latest Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
EPS (TTM)
My Lists My Alerts

09/30/2026 06/30/2026 03/31/2026 12/31/2025 09/30/2025
Revenue 39.15% 47.67% 42.23% 51.60% 22.12%
Total Other Revenue -- -- -- -- --
Total Revenue 39.15% 47.67% 42.23% 51.60% 22.12%
Cost of Revenue 52.09% 67.19% 65.81% 77.08% 6.79%
Gross Profit 35.83% 42.91% 34.84% 44.83% 26.81%
SG&A Expenses 26.37% 36.97% 36.63% 49.89% 11.75%
Depreciation & Amortization 66.15% 66.15% 66.15% 31.61% 0.00%
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 45.23% 56.84% 55.84% 61.11% 7.45%
Operating Income 35.36% 42.09% 30.37% 44.95% 33.53%
Income Before Tax 32.73% 39.02% 25.38% -156.59% 32.58%
Income Tax Expenses -0.35% 38.24% 17.66% -1.12% 55.43%
Earnings from Continuing Operations 40.99% 39.21% 27.06% -203.34% 27.89%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 40.99% 39.21% 27.06% -203.34% 27.89%
EBIT 35.36% 42.09% 30.37% 44.95% 33.53%
EBITDA 37.88% 44.11% 34.37% 43.47% 30.02%
EPS Basic 45.23% 44.04% 32.52% -211.02% 38.40%
Normalized Basic EPS 36.94% 43.84% 32.31% 53.71% 43.48%
EPS Diluted 40.56% 42.86% 31.18% -213.33% 36.19%
Normalized Diluted EPS 32.64% 42.40% 30.75% 56.83% 41.04%
Average Basic Shares Outstanding -2.92% -3.35% -4.12% -6.91% -7.59%
Average Diluted Shares Outstanding 0.23% -2.37% -2.98% -8.77% -6.00%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --